May 13 (Reuters)-
Daiken Medical Co Ltd
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Mar 31, 2022 Mar 31, 2021 Mar 31, 2023 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 8.54 7.86 8.75 4.17
(+8.6 pct) (-7.8 pct) (+2.5 pct) (+2.1 pct)
Operating 1.15 921 mln 1.20 520 mln
(+24.9 pct) (-22.9 pct) (+4.3 pct) (-8.0 pct)
Recurring 1.15 957 mln 1.20 520 mln
(+20.4 pct) (-20.9 pct) (+4.1 pct) (-8.0 pct)
Net 831 mln 675 mln 840 mln 360 mln
(+23.1 pct) (-21.4 pct) (+1.1 pct) (-10.1 pct)
EPS 28.93 yen 23.50 yen 29.24 yen 12.53 yen
Ann Div 20.00 yen 20.00 yen 20.00 yen
-Q2 Div 9.00 yen 9.00 yen 9.00 yen
-Q4 Div 11.00 yen 11.00 yen 11.00 yen
NOTE - Daiken Medical Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=7775.T